$1.06
0.93%
NYSE, Dec 26, 10:00 pm CET
ISIN
US44916K1060
Symbol
HYPR

Hyperfine Stock price

$1.06
+0.02 1.92% 1M
+0.33 44.97% 6M
+0.18 20.45% YTD
+0.19 21.42% 1Y
+0.17 19.10% 3Y
-8.95 89.41% 5Y
-8.95 89.41% 10Y
-8.95 89.41% 20Y
NYSE, Closing price Fri, Dec 26 2025
-0.01 0.93%
ISIN
US44916K1060
Symbol
HYPR

Key metrics

Basic
Market capitalization
$103.0m
Enterprise Value
$81.4m
Net debt
positive
Cash
$21.6m
Shares outstanding
80.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
9.7 | 7.6
EV/Sales
7.7 | 6.0
EV/FCF
negative
P/B
3.8
Financial Health
Equity Ratio
83.3%
Return on Equity
-83.0%
ROCE
-128.2%
ROIC
-281.2%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$10.6m | $13.6m
EBITDA
$-39.1m | $-36.0m
EBIT
$-40.2m | $-38.1m
Net Income
$-40.1m | $-37.4m
Free Cash Flow
$-32.2m
Growth (TTM | estimate)
Revenue
-20.1% | 5.2%
EBITDA
9.1% | 14.8%
EBIT
8.9% | 11.7%
Net Income
2.3% | 8.3%
Free Cash Flow
21.4%
Margin (TTM | estimate)
Gross
46.1%
EBITDA
-369.6% | -265.2%
EBIT
-379.4%
Net
-378.2% | -275.6%
Free Cash Flow
-304.3%
More
EPS
$-0.5
FCF per Share
$-0.4
Short interest
0.8%
Employees
111
Rev per Employee
$120.0k
Show more

Is Hyperfine a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Hyperfine Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Hyperfine forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Hyperfine forecast:

Buy
88%
Hold
13%

Financial data from Hyperfine

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
11 11
20% 20%
100%
- Direct Costs 5.71 5.71
20% 20%
54%
4.89 4.89
20% 20%
46%
- Selling and Administrative Expenses 26 26
2% 2%
249%
- Research and Development Expense 19 19
20% 20%
177%
-39 -39
9% 9%
-370%
- Depreciation and Amortization 1.04 1.04
0% 0%
10%
EBIT (Operating Income) EBIT -40 -40
9% 9%
-379%
Net Profit -40 -40
2% 2%
-378%

In millions USD.

Don't miss a Thing! We will send you all news about Hyperfine directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hyperfine Stock News

Neutral
Business Wire
11 days ago
GUILFORD, Conn.--(BUSINESS WIRE)--Swoop® portable MRI system receives CDSCO approval in India, expanding access to advanced brain imaging in a large, fast-growing healthcare market.
Neutral
Business Wire
13 days ago
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine secures FDA clearance for new DWI sequence, significantly expanding the Swoop® system's clinical capabilities in acute neurological care.
Neutral
Business Wire
about one month ago
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 AM ET.
More Hyperfine News

Company Profile

Hyperfine, Inc. is a medical device development company, which is engaged in the development of, MRI solutions and non-invasive neural monitoring technology. The company was founded by Jonathan M. Rothberg on February 25, 2014 and is headquartered in Guilford, CT.

Head office United States
CEO Maria Sainz
Employees 111
Founded 2014
Website hyperfinemri.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today